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ABSTRACT 
 
Background: Diabetes and obesity are major health concerns in the United States. There are 
several lifestyle factors that contribute to the development of these conditions and diet 
plays a large role in both etiology and treatment of these diseases. Poor carbohydrate 
quality and excess caloric intake can contribute to obesity and the development of insulin 
resistance, eventually progressing into Type 2 diabetes (DM2) and its associated co-
morbidities. Resistant starch (RS), a type of dietary fiber, is thought to be a tool for 
prevention and treatment of obesity and DM2 due to its slow release of glucose post 
prandially, low energy density, and colonic health benefits from fermentation in the colon.  
 
Methods: Twenty healthy non-overweight/obese weight (n=10; BMI 18.5-24.9 kg/m2) and 
overweight/obese (n=10; BMI > 25.0 kg/m2) consumed, in random order, 3 breakfast corn 
porridges providing 25 g starch derived from corn lines varying in levels of resistant starch. 
The porridges contained 3.1%, 8.4% and 28.9% RS of total starch. Post-prandial blood 
glucose was measured using a glucometer at baseline, 15, 30, 60 and 120 minutes. 
Postprandial satiety using a 100 mm Visual Analog Scales (VAS) was measured at baseline, 
30, 60, 120, and 180 minutes. Subjects recorded 24 h food intake and gastrointestinal 
symptoms upon completion of each visit. 
 
Results: There were no differences in post-prandial blood glucose, satiety, or food intake 
responses between non-overweight/obese and overweight/obese participants with 
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treatments. After data from the 2 weight groups were combined, mean plasma glucose at 
peak time-point 30 minutes was significantly lower in subjects consuming 28.9% RS 
treatment compared to the other treatments.  Baseline-adjusted plasma glucose AUC was 
also significantly lower in subjects consuming the 28.9% RS porridge compared to the other 
porridges. There were no differences in subjective satiety or 24-hour food intake. Minimal 
gastrointestinal symptoms were experienced in the 24 hours following all 3 test meals. 
 
 Conclusions: RS substitution improved acute and peak post-prandial glucose responses, but 
higher doses of RS (greater than approximately 30% or more of total starch, the maximum 
provided in our study) may be needed to increase satiety and decrease food-intake over 24 
h after ingesting the RS. 
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CHAPTER I: INTRODUCTION 
Background 
Resistant Starch intake is thought to control glucose and insulin levels, increase satiety, and 
lower calorie intake preventing obesity and insulin resistance. The purpose of this study was 
to examine the effects of a RS corn-porridge on postprandial blood glucose and satiety 
responses in ideal and overweight human subjects. It was hypothesized that non-
overweight/obese and overweight subject would have different glucose and satiety 
responses. Overweight subjects would have higher blood glucose and lower subjective 
satiety after all treatments. Plasma glucose was hypothesized to be lowest and satiety 
response would be highest in highest resistant starch treatment. Moreover, increased 
satiety with high resistant starch treatment would result in lower food intake over 24-hour 
period for all subjects. 
 
Thesis Organization 
This thesis will begin with a review of literature examining the role of carbohydrates in the 
development of obesity and DM2. The review will then shift its focus to resistant starch and 
its effect on post-prandial blood glucose, insulin, and satiety. The review will finish with 
general conclusions about resistant starch dosing and magnitude of effects. Following the 
review, the methods and results of the resistant starch human feeding study will be given. 
The thesis will conclude with discussion, appendices, references, and acknowledgements. 
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CHAPTER II: REVIEW OF LITERATURE 
Introduction 
Obesity and Type 2 Diabetes (DM2) are growing epidemics in the United States.  
Obesity has dramatically increased over the last 20 years, and this equates to about one 
third of the American population (CDC, 2011). Obesity is closely linked with Type 2 Diabetes 
as 80% of these individuals are obese and approximately 90-95% of diabetes cases in the 
United States are Type 2. There are 25 million people, 20 years of age and older, with 
diabetes, and 2 million new cases are diagnosed every year (CDC, 2011). These numbers are 
a cause for concern because of the negative health risks and early mortality associated with 
DM2. Long-term complications of chronic hyperglycemia from DM2 includes both 
marcovascular and microvascular complications (Nelms et al. 2007). Macrovascular 
complications can lead to heart disease and stroke. Microvascular damage can cause 
nephropathy leading to kidney failure, retinopathy resulting in blindness, and neuropathy 
eventually leading to amputation (Nelms et al. 2007). Several diet and lifestyle factors 
contribute to the development of obesity and DM2. In an observational study examining 
diet and lifestyles factors of  84,941 nurses over a 16-year period, incidence of DM2, 
physical inactivity, cigarette smoking, poor quality of fats and carbohydrates , and excessive 
calorie intake were significant risk factors for the development of DM2  independent of 
overweight or obese status (Hu, 2001).   Although these lifestyle factors contribute to the 
development of this negative health condition, obesity is the single most important risk 
factor for DM2, and high abdominal obesity, (absolute waist circumference >102 cm (40 in) 
in men and >88 cm (35 in) in women) regardless of weight categorization, is another critical 
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risk factor in DM2 development (Hu, 2011). Dietary factors are a key component in disease 
development and examination of intake patterns and macronutrient distribution will 
provide insight into the contributors of disease progression. Carbohydrates role in obesity 
and DM2 development will be addressed. This review will focus on intake data in the United 
States, structure and metabolism of carbohydrates and resistant starch (RS), and literature 
focusing on acute effects and mechanisms of RS on blood glycemia, satiety, and weight 
control. The ability of these acute effects to provide long-term protection against and 
treatment of obesity and DM2 will then be examined and summarized. 
 
Macronutrient intake patterns and Type 2 Diabetes development 
  Obesity is a critical factor in DM2 development. Consumption of energy intake 
greater than recommended needs can lead to weight gain and obesity. Obesity from greater 
intake and carbohydrates, more specifically RDS (rapidly digestible starch), contribute to 
manifestation and progression of DM2 (Schultze et al. 2004). This is supported by NHANES 
data comparing trends of energy and macronutrient intake in the United States between 
1971-1974 and 1999-2000 (Wright, 2004).   
Total energy and carbohydrate intake have increased while total fat, saturated fat, 
and protein have decreased. Mean intake of total kcals has increased 6% in men and 21% in 
females; carbohydrates supplying those kilocalories have increased 6% in both males and 
females. Total daily fat intake has declined 4% in men and 6% women, while saturated fat 
has declined 3% and 2% respectively (Wright, 2004). These are small percentages, but long-
term implications need to be realized.  For example, assuming 3,500 kcals equals 1 lb, a 6% 
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increase in kcals per day leads to a 12 lb weight gain in a one year and a 60 lb weight gain in 
4 years.  
 Although hypothetical implications, these data provide evidence for the increase in 
overweight and obese individuals in the United States through increased total energy and 
carbohydrate consumption. Interestingly, the most recent NHANES data trends comparing 
data between 1999-2000  and 2007-2008 show no change in total energy or fat intake, and 
a very slight decline in carbohydrate intake (1%) while incidence of obesity and DM2 have  
increased by an estimated 10% and 2% respectively over the last 10 years (Wright, 2010). 
These trends suggest diet quality, primarily carbohydrate quality for the purpose of this 
review, may have a role in obesity and DM2 development as several observational studies 
have found association between glycemic index and glycemic load and incidence of DM2 ( 
Halton et al. 2008; Krishnan et al. 2007; Villegas et. al 2007).  
 Quality of carbohydrates is commonly measured through glycemic index and 
glycemic load first developed by Jenkins and colleagues (1981).  The glycemic index (GI) 
ranks carbohydrates according to their effect on postprandial glucose area under the curve.  
GI values are expressed as a percentage of the blood glucose area under the curve 
compared to the same quantity of available carbohydrate in a standard product such as 
white bread or glucose. Glycemic index of foods are classified as low (<55), medium (56-69), 
and high (>70) GI foods. The glycemic load (GL) is calculated from GI and is used to estimate 
the rise in blood glucose from total amount of carbohydrate consumed. High GL per serving 
is > 20, medium GL per servings is 11-19, and low GL is < 10. It appears GI and GL may have 
a role in long-term health. In a meta-analysis of 37 observational studies conducted by 
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Barclay and colleagues comparing highest and lowest quintiles of GI and GL from food 
frequency data collected from 1 ,950, 198 subjects, found participants eating foods in the 
highest quintile of GI (median value 58) and GL (median value 142) had a higher relative risk 
ratio of chronic disease development of Type 2 diabetes, heart disease, colorectal cancer, 
endometrial cancer, and gallbladder disease. Barclay also found low GI (median value 49) 
and GL (median value 92) diets provided protective effects against incidence of chronic 
diseases including DM2 (Barclay et al. 2008). 
 Similar results were found in a prospective cohort study examining dietary intake  of  
37,846  participants using validated food-frequency questionnaires and incidence of 
diabetes as determined by risk ratios for an average follow up of 10 years. They found diets 
high in GL, GI, and carbohydrate, and low in fiber increased the risk of diabetes (Slujis et al. 
2010).   Halton et al. (2008) examined carbohydrate quality and quantity using semi-
qualitative food frequency questionnaires of 4,670 documented cases of type 2 diabetes of 
nurses followed for an average of 20 years and found a strong association (relative risk of 
2.47 above “gold standard” 1 for relative risk) between glycemic load of carbohydrates and 
DM2 incidence. Low-carbohydrate diets were not associated with decreased risk, but a 
trend for increased risk with greater carbohydrate consumption was documented. In a 
study of similar design, 59,000 US black women were followed for an average of 8 years and  
high glycemic index was found to be positively associated (relative risk 1.91) with DM2 
prevalence using relative risk of incidence, and fiber intake was found to be inversely 
related (relative risk of 0.41) with DM2 incidence (Krishnan et al. 2007).  Relative risk for 
DM2 increased as GI and GL increased in a cohort study of 64,227 Chinese women followed 
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for 4.6 years and increasing rice quantity of diet was also related to DM2 risk (Villegas et al. 
2007). These data support carbohydrate quantity and quality related to higher postprandial 
glycemia as one possible mechanism for disease progression and suggest that modifying 
type of carbohydrate in the diet can impact long term health.   
 
Starch Structure and characterization   
Starch is a major source of dietary carbohydrate that is an essential macronutrient 
for health. Starches are composed of polysaccharide chains consisting of two main 
structural components based on the α-linkages of the monosaccharides: amylopectin and 
amylose. Amylopectin is a highly branched structure of α-1,4 and α-1,6 glycosidic bonds 
that  create both short and long chains. Amylose is a linear, less branched structure of α-1,4 
bonds that can form different helices. Together they create different types of chemical and 
crystalline structures affecting the digestibility of starch (Englyst, 2006). Starch can be 
divided into three categories based on digestibility: rapidly digestible starch, slowly 
digestible starch, and resistant starch.  Rapidly digestible starch (RDS) is starch that is 
converted into glucose within 20 minutes of digestion in the small intestine. Slowly 
digestible starch (SDS) is fully digested within 20-120 minutes in the small intestine (Sajilata 
et al. 2006). 
Resistant starch (RS) is any starch that escapes digestion of the small intestine and 
passes into the large intestine to be metabolized. This indigestibility is caused by the 
crystalline structure that slows and prevents α-amylase from hydrolyzing starch into glucose 
to be absorbed by the small intestine (Perera et al. 2010).  Resistant starch is classified into 
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five categories: RS1-RS5. RS1 is starch that is physically inaccessible to digestion such as 
partially milled or whole grains, legumes, seeds, or pasta that are entrapped in a non-
digestible matrix. RS2 is raw or ungelatinized starch with a tightly packed crystalline 
structure reducing the accessibility of digestive enzymes and is found in foods such as raw 
potatoes, green bananas, and genetically modified high-amylose corn. RS3 is retrograded 
starch from cooking and cooling of granules. The amylose molecules that leak out of starch 
granules during gelatinization begin to reassociate as cooling begins increasing crystallinity 
of the starch structure, thereby increasing resistance to enzymatic digestion. RS4 is 
chemically modified starch that creates novel bonds between chains by cross-linking and is 
completely resistant to digestion (Fuentes-Zaragoza, 2010). RS5 is an amylose-lipid complex 
in starch that is resistant to digestion by retrograding amylase with free fatty acids to form a 
complex less susceptible to α-amylase. Most research examining metabolic benefits of 
resistant starch have used RS2 and RS3 starches, likely due to RS2’s abundance in  
commonly eaten foods and cooking and cooling of RS2  creates  RS3 (Murphy, 2008).  
Digestibility of starch fractions is an important concept that determines starch functionality 
in the body and influences health benefits. 
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Table 1: Description and sources of resistant starch  
Type of Resistant 
Starch 
Description Source 
RS1 Inaccessible starch 
trapped in a digestion 
resistant matrix 
Partially milled or whole grains, legumes, 
seeds, or pasta  
RS2 Raw or ungelatinized 
starch with a tightly 
packed crystalline 
structure 
Raw potatoes, green bananas, and genetically 
modified high-amylose corn 
RS3 Retrograded starch 
from recrystallization 
of amylose after 
cooking and cooling 
Bread and/or starch products cooked and 
cooled 
RS4 Chemically modified 
starch that creates 
novel bonds between 
chains by cross-linking  
Added to beverages, bread, cakes, porridges 
RS5 Amylose-lipid complex 
retrograded with free 
fatty acids  
Bread and other starch food products 
RS=resistant starch 
 
 
Methods of Measurement 
The measurement of RDS, SDS, and RS in vitro provides information on the rate and 
extent of starch digestion in the small intestine.  Methods for determining RS in food 
products vary among several protocol steps such as enzyme concentrations, types of 
enzymes, pH, temperatures and incubation periods. The basis for this discussion will focus 
on the Megazyme® kit as this is a widely used assay in determining RS of food products and 
Englyst’s methods (1982,1992).  Most recent protocols have been developed and modified 
from these proposed methods. Englyst and colleagues first developed a protocol for total RS 
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measurement in 1982, but it was later realized this assay only quantified RS3 as the 
homogenization, boiling and 40°C incubation eliminated RS1 and RS2 from total RS 
contribution. Englyst and others later modified this procedure in 1992 to measure all starch 
fractions by collecting sequential aliquots of sample during enzymatic hydrolysis at 20 
minutes and 120 minutes of digestion and measuring glucose contents of samples. The 
content of glucose at 20 minutes represents rapidly digestible starch (RDS). This glucose 
content is subtracted from glucose content at the 120 min aliquot from the beginning of the 
digestion and the remaining glucose concentration represents slowly digestible starch (SDS).  
Total RS is then measured indirectly from the following equation: RS = TS − (RDS + SDS).  RS1 
and RS2 are accounted for in this protocol because sample preparation by milling and 
boiling was omitted and temperature was no greater than 37 °C to more closely mimic 
human conditions, allowing RS1 and RS2 to remain unhydrolyzed. Megazyme® kit AOAC 
method 2002.02 and AACC Method 32–40 are widely used protocols for RS determination 
(Megazyme, 2008). It is only used to directly measure RS and does not measure RDS and 
SDS.  Samples are ground to pass a 1-mm sieve which allows RS1 to be accounted for in 
total RS measurement.  An α-amylase (3 Ceralpha Units/mg of activity) and 
amyloglucosidase (3300 U/mL) mixture is used  to hydrolyze starch in raw or processed food 
samples. Hydrolysis is carried out for 16 h at 37 °C leaving  RS2 in raw foods unhydrolyzed.  
Enzymes are inactivated after incubation with 99% ethanol, and glucose is removed by two 
washings with 50% ethanol.  Remaining starch pellets are collected from the digestion and 
treated with 2 M potassium hydroxide to extract RS3 from the fiber-rich matrix.  The 
dextrins produced from this extraction are hydrolyzed to glucose with amyloglucosidase 
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incubated for 30 min at 50 °C. Final glucose concentration is determined through a glucose 
oxidase-peroxidase colorimetric (Megazyme, 2008). Quantifying starch fractions provides 
valuable information about in vivo digestion and metabolism that can be used for 
determining health benefits of RS consumption. 
 
Starch metabolism 
Digestion of starch first begins in the mouth where salivary α-amylase begins to 
hydrolyze α-1,4 linkages of amylose and amylopectin forming dextrins. As dextrins reach the 
stomach they remain unchanged as α-amylase is inactivated by the low pH of the stomach 
(Gropper, 2009). Digestion continues in the small intestine by secretion of pancreatic α-
amylase that hydrolyzes α-1,4 linkages and dextrins into the disaccharide maltose. Brush 
border enzymes maltase and α-dextrinase form glucose from maltose and limit dextrins 
from the α-1,6 linkages of amylopectin  respectively. Glucose is actively transported into the 
mucosal cell where it enters circulation through facilitated diffusion and activates transport. 
Glucose is then carried to the liver to be metabolized and distributed in the body. Glucose 
leaves the liver through facilitated diffusion and is circulated to different tissues in the body 
(Gropper et al. 2009).  Glucose plays a key role in cellular homeostasis and metabolism and 
is needed as a continuous source of energy for most cells. Its concentration is closely 
regulated in the blood and it is distributed to tissues by glucose transporters. One 
transporter of particular importance is GLUT 4 which is widely distributed in muscle and 
adipose tissue. GLUT 4’s function of glucose uptake is insulin dependent, and insulin 
resistance plays a key role in the development of DM2. Adipocytes have been shown to 
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suppress expression of GLUT-4 with obesity and Type 2 Diabetes, and muscle cells have 
shown impairment in translocation of GLUT-4 to cell membrane in obesity and DM2 (Davies 
et al. 1994). Starch metabolism is essential to the understanding of DM2 development. 
 
Role of Starch in Type 2 Diabetes 
DM2 is caused by a complex interplay of both environmental and genetic factors 
that is caused by insulin resistance. Insulin resistance is the resistance of body cells to the 
action of insulin that results in impaired blood glucose metabolism (American Diabetes 
Association, 2009).  Abdominal obesity, excess calories, and diets high in RDS play a part in 
the pathophysiology of insulin resistance. Excess calories lead to obesity and this causes an 
overabundance of adipose tissue creating deleterious effects on insulin function which in 
turn affects glucose and lipid metabolism through large fat mass secretions of circulating 
levels of proinflammatory cytokines, hormone-like molecules, and other inflammatory 
markers (Balistreri, 2010). These secretions interfere with normal insulin function. Insulin 
resistance is a key component that precedes the onset of glucose intolerance and results in 
hyperinsulinemia with normal and high blood glucose concentrations (Bray, 2010).  
 Moreover, high consumption of rapidly digestible starches cause rapid spikes in 
blood glucose concentration (Ells, 2005) that leads to hyperinsulinemia and over time may 
contribute to the decline of insulin function. Ellls et al. (2005) compared postprandial blood 
glucose, insulin and non-esterifried fatty acids (NEFA) after consumption of a meal 
containing 75 g  rapidly digestible starches to 75 g slowly digestible starch with 21g of fat in 
10 healthy female volunteers. They found more rapid and higher peaks of plasma glucose 
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and insulin in the first 30-60 minutes after consumption of RDS meal and similar high and 
rapid peaks in NEFA 4-6 hours postprandial indicating starch type effects on carbohydrate 
and fat metabolism. In another study, RS produced comparable results in postprandial 
glucose, insulin, and NEFA after a meal tolerance test in 10 healthy subjects following 24 h 
consumption of 100g RS2 consisting of 60% RS distributed in 25g doses compared to 40g 
RDS delivered in 10g dose in a diet of 42% carbohydrate (Robertson et al., 2003).  These 
results show starch type can acutely affect insulin and glucose homeostasis and that long-
term intake of simple carbohydrates may affect carbohydrate and fat metabolism resulting 
in obesity and DM2. This is confirmed in research conducted by Pawlak et al. (2004) 
examining effects of dietary glycemic index on adiposity, glucose homoeostasis, and plasma 
lipids in rats fed high and low GI diets. Diets were of the same macronutrient content, (69% 
carbohydrate, 20% protein, and 11%) but rats fed a high GI diet were fed starch made of 
60% amylose and rats fed a low GI diet were fed starch made of 100% amylopectin.  Rats 
fed the high GI food had similar body weight compared to low GI but almost twice the 
amount of body fat and less lean body mass. Rats fed high GI diet had greater areas under 
the curve for blood glucose and plasma insulin after a glucose tolerance, lower plasma 
adiponectin concentrations (levels are inversely associated with obesity), higher plasma 
triglyceride concentrations, and severe disruption of pancreatic islet-cell architecture. 
 When Pawak and others (2004) conducted a similar experiment with high and low 
fat diets, they found no difference in body fat accumulation between treatments, but less 
glucose uptake and plasma insulin in rats fed the high-fat diet. These findings suggest both 
excess fat and carbohydrates play a role in the development of DM2. Although when wild-
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type Drosophila melanogaster (fruit flies) were fed high-fat, high-sugar, and control diets, 
larvae fed high-sugar diets developed hyperglycemia, obesity and insulin resistance, while 
insulin resistance was not seen in the high-fat diet suggesting carbohydrates play a greater 
role in the decline of insulin function (Musselman et al. 2011). 
 As insulin function declines glucose intolerance ensues causing high blood glucose 
levels that are harmful to the macro and micro vascular function resulting in DM2 diagnosis. 
According to the American Diabetes Association, Type 2 Diabetes is diagnosed by classic 
symptoms of the disease with one of three criteria: 1) casual plasma glucose concentration 
> 200mg/dL (11.1mmol/L) 2) Fasting plasma glucose > 126 mg/dL (7.0 mmol/L) 3) plasma 
glucose >200mg/dL 2-hours postprandial an oral glucose tolerance test. A positive test 
should be followed with a repeat testing on a different day (ADA, 2009). Better 
understanding of the physiological effects of carbohydrates on metabolism will help 
develop recommendations for intake of carbohydrates and resistant starch. These will be 
important for improving health and combating the globalization of obesity and DM2. 
 
Metabolic effects of resistant starch 
  Several factors determine resistant starch formation and metabolic effects of RS. 
Chemical structure, processing of RS, endogenous influences, nutrient interactions, and 
meal factors will give certain physico-chemical characteristic of starch influencing 
gastrointestinal handling (Englyst, 2005). Inherent structure and physical properties of 
resistant starch such as increased crystallinity, granular size, amylose content, and amylose 
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retrogradation will increase resistance to digestion (Sajilata, 2006). Processing conditions 
and metabolism of starch determines the amount of starch that is available to be absorbed 
in the small intestine and is reflected in elevation and duration of rise in postprandial blood 
glucose.  Metabolism, or lack thereof, also determines amount of resistant starch left in the 
large intestine through measurement of fermentation and production of short chain fatty 
acids (Englyst, 2006). Control of glucose levels, fermentation of hydrolyzed starch, and 
decreased energy intake from undigested starch are the basic principles behind the 
beneficial physiological effects of RS as it relates to obesity and DM2.  
 
Glucose Metabolism and Insulin responses of resistant starch 
Resistant starches affect postprandial glucose levels through three common 
mechanisms: inhibiting α-amylase from digesting starch into glucose, increasing the 
viscosity of chyme in the small intestine which slows the rate of glucose uptake, and binding 
glucose which prevents its diffusion into the mucosal cells. These mechanisms were 
determined through in vitro comparison analysis of glucose diffusion, absorption/binding, 
and α-amylase activity in glucose-fiber complexes of RS, water insoluble, and water soluble 
fibers (Ou et al. 2001).  
Several studies have confirmed lowering of postprandial blood glucose and insulin 
after consumption of RS. When a test meal of mixed macronutrients containing 50g of RS3 
was compared with 50g of fully digestible cornstarch in 8 subjects, the retrograded amylose 
meal lowered AUC in both glucose and insulin during absorptive state. Bloods samples were 
taken up to 27 hours after ingestion, but no difference was seen between glucose and 
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insulin in post absorptive state, suggesting acute effects for application and benefits of RS3 
consumption  (Achnor et al. 1997). In another study examining healthy adults for 10 weeks, 
12 males consumed a diet containing 70% high amylose for 5 weeks and a diet containing 
70% high amylopectin for 5 weeks compromising 66% of total carbohydrate for weekly 
meals (Behall et al. 1989). At the end of each 5 week diet, a glucose tolerance test and 
starch load test containing 16% RS2 (1g/kg of bodyweight) were administered and 
postprandial insulin and glucose test were measured accordingly. They found total insulin 
and glucose (AUC) responses were not significantly different between treatments. However, 
acute ingestion of high amylose resulted in significantly lower glucose levels during the first 
hour and higher at 3 hours after ingestion compared to amylose control, and insulin levels 
were lower in first 2 hours compared to control still providing protection against glucose 
and insulin spikes that are detrimental to long-term health (Behall et al., 1989). Vans 
amelsvoort and Westrate (1992) found peaks in postprandial glucose and insulin curves at 
30 minutes for high and low amylose meals. Low-amylose meals (0%) induced higher 
postprandial insulin concentrations at 0.5 and 1 hours resulting in significant increases 
(55%) in absolute and net glucose AUC compared to high-amylose meal. High-amylose 
treament had higher glucose levels 2 and 6 hours postprandial confirming slow release of in 
hot meals of mixed macronutrients. Peaks in glucose and insulin found  were similar, at 30 
and 45 minutes respectively for all treatments, in  Li and colleagues (2010) experiment 
comparing postprandial insulin and glucose responses in 16 healthy subjects of ideal body 
weight after consumption of RS2 rice (8g in 40 carbohydrate load), white rice, and glucose. 
RS (GI of 48) and white rice (GI of 77) both had significantly lower glucose and insulin AUC 
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compared to glucose load. The glucose and insulin AUC of RS rice was still lower than white 
rice confirming the potential of GI.  Kendall et al. (2010) had subjects consume a beverage 
and cereal bar of 0g, 5g, 15g, and 25g of RS3 and found no difference between glucose and 
insulin AUC. However, there was trend for a decline in glucose after the 25g RS treatment 
compared at 90 minutes in the 15g RS treatment, and 90 and 120 minutes in 0g RS 
treatment. Insulin showed a similar pattern with the 25g RS cereal bar at 60 minutes 
compared with the 15g RS treatment and 90 and 120 minutes of 0g RS treatment (Kendall 
et al., 2010). Higher doses of RS3, 50 grams or more, may be needed to produce significant 
declines in postprandial plasma glucose and insulin.  
It is clear percent of amylose and RS, and total RS play a role in the effect of 
postprandial glucose and insulin levels. Behall and others (2002) examined these effects in 
breads containing different levels of amylose (30%, 40%, 50%, 60%, and 70%) and percent 
RS2 (2%, 8%, 12% and 15%).Twenty-five normal and overweight men and women ate a 2-
day controlled diet and underwent a tolerance test with either a glucose solution or a test 
bread containing an equal amount of total carbohydrate. Plasma glucose concentration was 
significantly higher at 0.5 and 1 hours and lower at 3 hours after the glucose than after any 
bread. Peak glucose concentrations after breads containing 50-70% amylose starches were 
significantly lower than peak concentration after the 30 -40% amylose breads and insulin 
levels showed a similar pattern. Lower glucose and insulin responses were seen with 
increased RS2 percentage in test breads. It was concluded starch levels greater than 50% 
amylose are needed to produce biologically significant declines in plasma glucose and 
insulin levels. A combination of RS and soluble fiber (β-glucan) provide greater effects on 
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postprandial insulin and glucose levels than RS alone. Behall et al. (2006) had subjects 
consume 1 g carbohydrate per kg body weight as a glucose solution plus 100 g water or a 
test muffin containing an equal amount of total carbohydrate. High RS muffins contained 
5.06 g resistant starch/100 g muffin, high soluble fiber muffins contained 2.3 g beta-
glucan/100 g muffin and combined muffins contained 8 and 2 grams respectively. The 
greatest reduction occurred in meals containing both high β-glucan and resistant starch (33 
and 59% lower AUC for glucose and insulin, respectively).  Although high resistant starch 
muffins provided better control of glucose levels compared to high β-glucan muffins alone 
(Behall et al. 2006).  This study also compared responses between ideal (n=10) and 
overweight (n=10) women according to BMI. Glucose and insulin responses were improved 
in both groups, but overweight women had higher insulin  levels than their ideal 
counterparts concluding overweight women were somewhat more insulin resistant despite 
having similar glucose responses between treatments. 
  Hyperinsulinemia is a critical factor that precedes insulin resistance and Behall and 
others (1995, 2005) conducted two studies comparing normal and hyperinsulinemic (HI) 
subjects consuming low and high amylose diets. In their first study, hyperinsulinemia was 
determined by fasting insulin and an insulin/glucose tolerance test (Behall et al, 1995). 
Subjects (n=24) ate 10 weeks of self-selected foods containing high in amylose (70%) or 
amylopectin (70%) followed by 4 weeks of a control diet with 55% of carbohydrates 
containing 70% amylose.  Starch load test were conducted at weeks 4, 8, and 13 of high 
amylopectin or high amylose diets measuring postprandial glucose and insulin. Both groups 
had a decline in blood glucose levels in high-amylose treatment compared to high 
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amylopectin treatment. HI subjects had a 43.1%, 0%, 32.2% decline at 4, 8, and 13 weeks 
respectively compared to high-amylopectin and control subjects and similar reductions. 
There was a trend for glucose levels to be higher in HI subjects (n=14) after high-amylose 
treatment, but this was not significant although insulin levels were significantly higher 
between the two groups. Insulin decreased in both control (39.7%, 33.6%, and 47.9%) and 
HI (35.6%, 25.4%, and 47.7%) subjects on high-amylose diet for all three measurements 
respectively. Furthermore, HI subjects had higher glucose and insulin levels compared to 
ideal subjects after consuming high-amylopectin diets which would be expected in HI 
individuals. In their second experiment (Behall & Schofield, 2005), subjects underwent a 
meal tolerance test containing high-amylose or amylopectin (70%) chips (8-12g of RS) and 
muffins (16-25 of RS). Both HI and normal subjects had lower glucose and insulin after high 
amylose meals at 30 minutes for glucose and 1 hour with insulin.  Average plasma glucose 
and insulin area under the curves after high-amylose foods were approximately 50% those 
after high-amylopectin foods although hyperinsulinemic subjects had significantly higher 
insulin and glucose responses and AUC compared with the normal responders. From both 
studies, it can be concluded that high-amylose diets can help lower glucose and insulin 
levels in ideal and overweight, normal and hyperinsulinemic individuals. 
 Aside from reductions in postprandial glucose and insulin, RS has also been shown 
to improve insulin sensitivity. Robertson and colleagues (2003) examined the effect of 24-
hour RS (50 grams 60% RS) consumption on insulin sensitivity. Glucose and insulin curves 
were lower following high-RS diet compared to control. Insulin sensitivity following high-RS 
diet increased using the minimal model approach but not using homeostasis model 
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assessment. In a similar study comparing 4 weeks of high and low RS diet (100 grams 60% 
RS) insulin sensitivity was measured using the hyperinsulinemic-euglycemicclamp 
(Robertson et al. 2005). Resistant starch supplementation significantly increased insulin 
sensitivity and mean muscle glucose clearance per pmol/L insulin increased by 44% during 
meal tolerance test, and insulin sensitization of adipose tissue was also increased. These 
finding suggest higher doses of RS2 (greater than 50g) and long-term consumption is 
needed to ensure increase insulin sensitivity from RS supplementation. Furthermore, insulin 
sensitivity and RS consumption in persons with  type 2 diabetes needs to be assessed to 
make better recommendations.  
 
 
Table 2: Comparison of glucose and insulin responses from resistant starch supplementation in               
jjjjjjjjjjjjjjjhumans 
Authors Subjects Methodology Test Meal Measurements Results 
Anchor et. Al 
1997 
n=8 
Age: 27 y.o. 
Sex: 6 F, 2 M 
 
Healthy 
adults of ideal 
weight 
Cross-over 
design of two 
27 hour   
test meal of  
high RS and 
low RS 
cornstarch 
consisting of 
632 kcals 
32% fat, 56% 
carbohydrate, 
and 12%  
protein  
 
RS3 (50g, 70% 
amylose) in 
porridge  
 
(Hylon VII; 
Cerestar) 
Post prandial 
glucose and 
insulin, and 
satiety 
response in  
absorptive and 
post-
absorptive 
states 
Retrograded 
amylose 
lowered AUC 
in glucose and 
insulin during 
absorptive 
state. 
 
No difference 
between 
glucose and 
insulin found in 
post 
absorptive 
state or satiety 
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Table 2. (continued) 
Behall et al. 
1989 
n=12 
Age: 34 y.o. 
Sex:  M 
 
Healthy adults 
of ideal body 
weight 
 
Cross-over 
design 
measuring 
glucose 
tolerance and 
starch load 
test  at  end of 
each  5 week 
period of diets 
with 66% of 
carbohydrates 
containing 70% 
amylose or 
70% 
amylopectin 
 
16% RS2 
distributed 
within daily 
meals and in 
starch cracker 
loads 
 
(American 
Maize-
Products 
Company, 
Hammond, IN) 
Postprandial 
glucose and 
insulin 
responses 
 
Glucose and 
insulin 
tolerance  
 
 
Amylose load 
produced 
lower glucose 
in first hour 
and higher at 3 
hours  and 
lower insulin 
levels in first 2 
hours 
 
Glucose and 
insulin 
tolerance 
between diets 
were not 
different 
Behall & Howe 
1995 
n=24 
Age: 41: y.o. 
Sex:  F, M 
 
Ideal and 
overweight HI 
(14) and non-
HI (10) adults 
 
Starch load 
test at  week 4, 
8 and 13 in 14 
week cross-
over design of 
10 weeks self-
selected 
amylose or 
amylopectin 
diets and 4 
week control 
diets of diets 
with 55% of 
carbohydrates 
containing 70% 
amylose or 
70% 
amylopectin 
 
 RS2  (16%) 
distributed 
within daily 
meals and in 
starch cracker 
loads 
 
(American 
Maize-
Products 
Company, 
Hammond, IN) 
Postprandial 
glucose and 
insulin 
responses 
Insulin higher 
in HI subjects 
in amylose and 
amylopectin 
than non-HI 
subjects 
 
Glucose higher 
in HI subjects 
on 
amylopectin 
treatment 
 
Amylose starch 
load reduced 
glucose (NS) 
and insulin 
responses in 
both normal 
and HI subjects 
~0%-47% 
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Table 2. (continued) 
Behall & 
Hallfrisch 2002 
n=25 
Age: 41 y.o. 
Sex: 12F, 13M 
 
Ideal and 
overweight 
healthy adults 
2 Day 
controlled diet 
followed by 
tolerance test 
of glucose 
solution or 
breads 
containing 
30%, 40%, 
50%, 60%, 70% 
amylose 
breads 
RS2 (2, 8, 12 
and 15%) in 
breads 
 
(American 
Maize-
Products 
Company, 
Hammond, IN) 
Postprandial 
glucose and 
insulin 
tolerance 
Glucose and 
insulin  AUC 
with glucose 
solution 
concentrations 
than all breads 
 
60-70% 
amylose 
breads 
lowered insulin 
and glucose 
response than 
all other 
breads 
 
>50% amylose 
needed for 
significant 
change in 
postprandial 
blood glucose 
and insulin 
Behall et al. 
2006 
n=20 
Age: 43 y.o. 
Sex: F 
 
Adults of Ideal 
(10) and over 
weight (10) 
body weight 
Cross-over 
design of 2 day 
controlled diet 
followed by 
tolerance test 
of glucose 
solution and 
muffins 
containing low, 
medium and 
high RS 
RS2 (0.71, 
2.57, or 5.06 
g/100 g 
muffin) and β-
glucan (0.26, 
0.68, or 2.3 g 
β-glucan/100 g 
muffin) in 
muffins 
 
 (American 
Maize-
Products 
Company, 
Hammond, IN) 
Postprandial 
glucose and 
insulin 
responses 
No differences 
between 
weight groups 
in glucose 
response but 
differences 
with insulin 
response. 
 
High RS 
treatment ↓ 
glucose (59%) 
and insulin 
(38%) AUC 
compared and 
low RS 
treatment 
 
Insulin and 
glucose 
responses ↓ 
as RS increased 
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Table 2. (continued) 
Behall & 
Scholfield 2005 
n=24 
Age: 25-57 y.o. 
Sex: 12 M, 12 F 
 
HI and non-HI  
adults of ideal 
body weight  
Four test 
meals: of  
muffins  or 
corn chips or 
made with 
starch or 
cornmeal that 
contained 70% 
amylose or 
amylopectin  
RS2 in corn 
chips (8 g) and 
muffins  (24g) 
in 60-70 g 
carbohydrate 
meal 
 
(American 
Maize-
Products 
Company, 
Hammond, IN) 
Postprandial 
glucose and 
insulin  
High amylose 
chips and 
muffins 
resulted in 
lower average 
insulin and 
glucose 
response  
 
HI subjects had 
higher insulin 
and glucose 
responses 
compared to 
normal 
individuals 
Kendall et al. 
2010 
n=22 
Age: 26 y.o. 
Sex: 9 F, 13 M 
 
Healthy adults 
of ideal body 
weight 
5 tests meals 
consisting of 
cereal bar and 
beverage of 
varying  levels 
of RS 
RS3 (58%, 0g, 
5g, 15g, & 25g) 
in cereal bar  
 
(PROMITOR™ 
Tate and Lyle 
Ingredients 
America, 
Decatur, IL) 
Postprandial 
glucose and 
insulin 
responses 
(fingerpick 
analysis) 
Glucose & 
insulin AUC 
were not 
different 
 
Acute (<60 
mins) insulin 
and glucose 
responses 
were not 
different 
 
Hasjim et al. 
2010 
n=20  
Age: 19-38 y.o. 
Sex: M 
 
Adults of ideal, 
overweight, 
and obese 
body weight 
Randomized 
cross-over 
design of 2 test 
meals 
consisting of 
RS bread 
treatment and 
white bread 
control  
RS5 (50g, 37%) 
in bread 
 
(Iowa State 
University, 
Ames, IA) 
Postprandial 
glucose and 
insulin 
response 
Glucose (55%) 
and insulin 
(43%) iAUC  
reduced 
compared to 
control 
 
Mean glucose 
and insulin 
concentration 
were different 
by treatment 
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Table 2. (continued) 
Li et al. 2010 n=16 
Age: 24 y.o. 
Sex: 7 F, 9 M 
 
Adults of ideal 
body weight 
Cross-over 
design of 3 test 
meals of 
glucose, RS rice 
and white RS 
rice 
RS2 (8g, 20%) 
in rice in 40g 
carbohydrate 
meal 
 
(Agricultural 
College of 
Yangzhou 
University, 
Jiangsu 
Province, 
China). 
Postprandial 
glucose and 
insulin 
response 
Glucose and 
insulin AUC 
reduced by RS  
Van 
amelsvoort & 
Weststrate 
1992 
n=22 
Age: 40 y.o 
Sex: M 
 
Adults of 
overweight 
and ideal body 
weight  
Cross-over 
design of test 
meals  (hot 
mixed lunch) 
of l with low-
amylose (0%) 
and high 
amylose (55%) 
RS3 in Rice in 
65-122 g 
carbohydrate 
per meal 
 
(Hylon VII, 
National Starch 
and Chemical 
Co) 
Postprandial 
glucose and 
insulin 
response 
Glucose lower 
at 0.5, 1 hours 
and higher 2, 
4, 6 hours  in 
high-amylose 
meal 
 
Insulin higher 
at 0.5, 1 hours 
and greater 
net and 
absolute AUC 
in low-amylose 
meal 
Robertson et 
al. 2003 
n=10 
Age: 47 y.o. 
Sex: 6 F, 4 M 
 
Adults of 
overweight 
and ideal body 
weight 
Cross-over 
design of  meal 
tolerance test 
after 24hr 
diets of low 
and high RS 
RS2 (100g, 
60%) in jelly 
 
(Novelose 260, 
National Starch 
and Chemical, 
Manchester, 
UK) 
Postprandial 
glucose and 
insulin 
response 
Glucose and 
insulin 
response lower 
and insulin 
sensitivity 
improved after 
24-hr diet of 
high RS 
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Table 2. (continued) 
Robertson et 
al. 2005 
 
 
 
 
 
n=10 
Age: 48 y.o. 
Sex: 6 F, 4 M 
 
Adults of ideal, 
overweight, 
and obese 
body weight 
Cross-over 
design of 4-
week periods 
of high and 
low  RS diet 
RS2 (50g, 60% ) 
mixed in daily 
meals from 
sachet(97.9 
MJ/d during 
the RS) 
 
 (Hi-maize 260, 
National Starch 
and Chemica, 
Manchester, 
UK) 
Hyperinsuline
mic-
euglycemic 
clamp and 
postprandial 
glucose and 
insulin after 
meal 
tolerance  
tests  
Glucose 
clearance 
faster after 
MTT with 
lower insulin 
after RS 
treatment 
 
 
RS=resistant starch, HI=hyperinsulinemic, NS=not significant 
 
Collectively, these studies (Table 2) indicate that doses of 40-60grams of starch 
containing 50-70% amylose starch and > 15% RS2 can lower postprandial insulin and 
glucose response and higher doses of RS3 may be needed to produce similar effects. To 
improve insulin sensitivity, 100 gram daily doses of total RS over a period of weeks may be 
needed to produce significant effects.  The results also reiterate the idea that normal starch 
is digested immediately and can cause major spikes in postprandial blood glucose. Slower 
rates of starch absorption from RS may be a useful tool for reducing postprandial glycemia 
and insulinemia by releasing glucose over a longer period and thereby providing better 
control of blood glucose and insulin that would be helpful for individuals with diabetes. 
Several studies have shown improved postprandial blood glucose and insulin in DM2 
individuals after consumption of RS. In a study comparing insulin and glucose responses in 
subjects with DM2 after consumption of a resistant starch bar, traditional energy bar, and 
candy bar; the resistant starch bar had 50% reduction in glucose AUC, and similar trends in 
25 
 
plasma insulin between the RS and traditional bar, but not the candy bar (Reader et al., 
2002). Johnston and others (2010) found 40g of 60% RS2 improved insulin sensitivity after 
12 weeks of supplementation in 20 volunteers with Type 2 Diabetes. Furthermore, Mitra 
and colleagues (2007) found 12 weeks of 150g/day of RS3 rice (8-10% RS) lowered fasting 
blood glucose, total cholesterol, and LDL cholesterol in persons with DM2. These results 
confirm RS supplementation can be beneficial tool for both normal and diabetic individuals 
in controlling postprandial glucose and insulin levels. 
 
Fermentation of Resistant Starch 
Unhydrolyzed starch is fermented by bacteria in the large intestine resulting in the 
fermentation products such as carbon dioxide, methane, hydrogen, organic acids, and 
short-chain fatty acids (SCFA). Fermentation can be measured through hydrogen breath 
tests and SCFA concentration in feces. Consumption of 17-45 grams of RS2 and RS3 (RS3 at 
lower doses and RS2 and the higher doses) meals have been shown to increase fecal bulk 
(Phillips et. Al 1995, Noakes et al., 1996), breath hydrogen (Van Munster, 1994) and fecal 
SCFA  (Phillips,1995; Cummings,1996; Noakes et al. 1996; Jenkins,1998). Increase in fecal 
bulk is a direct result of increased RS in the large intestine and is correlated (r=0.70)  with RS 
consumption  (Phillips; 1995).  It is used as a measure for confirmation of indigestibility. For 
example, 26-30 grams of RS2 from banana and potato flour has been shown to increase 
stool weight 31 and 34 grams per day respectively, while 17-19 g of RS3 from wheat flour 
and maize has been shown to increase stool weight by 46 and 49 g per day (Cummings 
1996). Confirmation of indigestibility can also be measured through breath hydrogen. 
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 Van Munster et al. (1994) measured breath hydrogen concentration after 
consumption of 15 g of RS2 three times a day for 7 days in 22 healthy male volunteers, and 
breath hydrogen began to increase 4 hours and peaked 12 hours after consumption. SCFAs 
acetate, propionate, and butyrate increased after the RS supplementation in stool samples 
collected after a 4-week high amylose diet compromising of approximately 33 and 48 grams 
of RS for 10 overweight women and 13 overweight men respectively (Noakes; 1996). This 
also resulted in a reduced colonic pH compared to a 4-week low amylose diet. Phillips et al. 
(1995) had similar results after 11 ideal and overweight, male and female subjects 
consumed a diet of mixed RS types containing 4.67 mg RS/kJ for an average 38 g of RS per 
day. They found significant correlations between RS consumption and total fecal output 
(r=0.85), fecal pH (r=-0.82), and fecal butyrate excretion (r=0.84).  Total SFCAs were also 
increased in Jenkins’ et al. (1998) experiment after subjects consumed separate, 30g RS2 
and RS3 breakfast meals for 2 weeks, and butyrate showed the greatest increase of the all 
SCFA compared to control.  In Cummings et al. (1996) acute human feeding study of 3 
separate daily meals containing a total of 26-30g RS2, 17-19 grams of RS3, and a control, 
results showed no significant increases in SCFA. However, there was a trend for increase in 
total SCFA with no change in butyrate, but increase in acetate and propionate in RS2 and 
RS3 respectively. Lack of findings may be due to short duration and lower levels of RS 
consumption in subjects.  
These studies indicate 30g or more of RS a day is needed to provide biologically 
significant increase in short chain fatty acids, and decrease in colonic pH.  It also suggests 
type of SCFA produced may depend on profile of microflora or even type of RS in the large 
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intestine as many of these studies had mixed results of SFCA production.  Metabolism of 
different SCFA is an interesting topic and important to consider when looking into colonic 
health benefits.  
 
Benefits of Fermentation 
Increased SFCA’s from RS consumption provide benefits to the colon through 
lowering pH and reducing DNA damage (Conlon et al.  2012). Fermentation of resistant 
carbohydrates in the large intestine provide benefit by reducing ammonia and phenol 
excretion in feces (Birkett, 1996). Unhydrolyzed starch adds bulk to feces and acts as 
substrate for fermentation by bacteria allowing SCFA to be produced and pH to be reduced. 
Lower colonic pH has been shown to have anti-carcinogenic effects in both rats and 
humans. Rats fed high amylose resistant starch that increased butyrate production showed 
higher rates of apoptosis in DNA damaged colonocytes (Clark et al. 2012)  and butyrate 
appears to have a mechanistic role for inducement of apoptosis in colorectal cancer cell 
lines (Shin et al. 2012).  Furthermore, Walker et al (1986) studied human populations in 
South Africa with differing levels of colon cancer incidence and found lower fecal pH in the 
low disease incidence populations despite similar fiber intake, but RS was not measured in 
this study and the populations of the low colorectal incidence consumed a greater amount 
foods high in RS such as maize and bean products. These studies suggest lower pH and 
possibly specific SCFA butyrate, play a role in protection from colon carcinogenesis.   
 SFCAs acetate, butyrate, and propionate produced in the colon are absorbed by the 
intestinal cells to be used for energy or enter the portal vein for distribution in the body 
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(Cummings, 1987). Additionally, butyrate appears to be the preferred energy source for 
cultured cells in the colonic mucosa (Shin et al. 2012). Butyrate health benefits tend to 
relate towards colonocyte health and propionate and acetate have been proposed to 
provide hypophagic effects by acting as ligands to G-protein coupled receptors mediating 
lipid metabolism through adipocyte formation by adipokine release (Arora, Sharma, & Frost, 
2011). SCFAs from resistant starch consumption play a complex role in colon health as RS 
has also been shown to reduce DNA damage in rats. Conlon and others (2012) found 
sprague-dawley rats fed a high amylose RS diet had significantly less (70%) single strand 
DNA breaks compared to rats fat low RS diet. They also found increased fecal SCFA (high 
concentration of butyrate), lower phenol and ammonia excretion in feces, and increased 
colonic microbiota in rats fat high RS diets.  Phenols and ammonia are toxic compounds 
produced as byproducts of protein fermentation in the colon. Phenols produce carcinogenic 
effects and ammonia is a cytotoxic compound (Visek, 1978).  Protein fermentation by-
products were reduced in fecal samples collected by Birkett and colleagues (1996) from 5 
male and 6 female subjects after a 3 week cross-over design of low-and high RS diet 
containing RS1 and RS2 from wheat and banana flours distributed in daily diets. They found 
the high RS diet reduced ammonia and phenol, and increased nitrogen excretion. Reduced 
excretion of toxic byproducts occurs because the bacteria in the large intestine  readily use 
the unhydrolzed starch for energy decreasing the amount of protein that is fermented and 
nitrogen is increased from the growth in microbiotic mass  (Birkett, 1996).   Resistant Starch 
plays an important role in colonic health, but further research is needed to determine 
29 
 
specific mechanisms behind digestion and metabolism of RS in the colon that lead to these 
health benefits. 
 
Resistant Starch influence on Satiety and Weight Control 
Food intake is determined by internal and external factors that produce different 
satiation effects (hunger, fullness, satisfaction and desire to eat). Satiety and appetite 
regulation are very complex and are influenced by several factors such as environmental 
cues, psychological perceptions of hunger, and individual metabolism and physiology that 
produce neuronal cues leading to ingestion of food (Bornet et al. 2007). Meal factors 
influence amount of macronutrients and rate of digestion. This in turn affects gut hormones 
and peptides such as insulin, ghrelin, cholecystokinin (CCK), peptide YY (PYY), glucagon-like 
peptide-1 (GLP-1), and gastric inhibitory polypeptide (GIP) that regulate appetite (Table 3) 
 
Resistant starch has been 
proposed to influence satiety 
and control weight through 
several different mechanisms. 
One mechanism is the steady 
release of postprandial blood glucose from consumption of resistant starch.  This delays the 
decline in blood glucose to pre-meal levels that would signal hunger and increase appetite. 
This relates to Jean Mayer’s glucostatic theory (1953) elucidating the effect of glucose levels 
Table 3: Effect of satiety peptides on appetite 
Satiety Peptide Origin Effect on Appetite 
Ghrelin Stomach ↑ appetite 
PYY Large intestine ↓ appetite 
CCK Small intestine ↓ appetite 
GLP-1 Large intestine ↓ appetite 
Leptin Adipose tissue ↓ appetite 
Adapted from Druce, M. R. ;Small, C. J. ;Bloom, S. R.  Endocrinology 145, 
2004. 
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on appetite as he found low glucose levels are associated with hunger in both normal and 
insulin resistant individuals.  
A second mechanism of decreased satiety through resistant starch supplementation 
is the interaction between SCFAs in the colon and satiety hormones. Short-chain fatty acids 
in large intestine are proposed to increase satiety by their release form the hepatic, portal, 
and venous blood that reduce production of fatty-acids from visceral adipose tissue 
(Cummings et al. 1987) and consequently effects physiology of metabolism and neuronal 
pathways of food intake.  
A few studies have shown interaction between fermentation of RS, increase SCFAs, 
and changes in satiety hormones in both rats and humans. In a series of experiments by 
Zhou and others (2008), Sprague-Dawley rats fed resistant starch showed increased GLP-1 
and PYY expression and secretion compared to control. When seven overweight and obese 
human subjects consumed 4 g of RS3 (barely and oat mixture) per day for 14 weeks, fasting 
GLP-1 and PYY were increased as well as satiety 1 hour after a standard meal (Greenway et 
al. 2007). Decreased satiety through SCFA effects on satiety hormones has basis, but more 
research is needed to substantiate these claims and identify mechanisms.  Controlling body 
weight by RS consumption is achieved through to basic mechanisms: 1) increased satiation 
reduces subsequent food intake 2) less metabolizable energy in resistant starch compared 
to normal starch of same load give less energy intake and less energy intake leads to weight 
loss or weight control.  The energy contribution of digested RS can range from 0 to 100% 
and up to 70% of RS can be metabolized in the large intestine. This depends on type and 
product of RS and subsequent processing in the colon (Cummings et al. 1996).  
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 There are a limited number of studies examining the effects of RS on satiety and 
food intake and even fewer on corresponding satiety peptides. Moreover, evidence for 
increased satiation and reduced food intake has shown mixed results. Anderson et al. 
(2010) examined second meal intake of 17 healthy males 2 hours after consumption of a 3 
tomato soups containing 50 g of RS. Amount of RS in soup treatment was correlated with 
reduced food intake at 120 min. The whole-grain soup (27g RS2), high-amylose soup (23g 
RS2) and regular cornstarch soup (19g RS2) had a 17%, 10%, and 10% decline in food intake 
respectively. Additionally, whole-grain soup was the only treatment that resulted in lower 
cumulative energy intake and there was a trend for decline in average appetite area under 
the curve after RS treatments compared to control. The decline in food intake was thought 
to be caused by the release of SDS that occurs up to 120 minutes post-prandial and types 
fiber sources may play a role in differences between results. In a study where postprandial 
satiety was compared in 5 muffins of different fiber content (9g of RS2, β-glucan, oat, corn 
bran, polydextrose)  in 20 subjects, Willis and others (2009) found RS muffins were the most 
satiating in satisfaction and fullness up to 3 hours postprandial, and corn bran muffins had 
similar results for fullness only. Prospective consumption measured on 100mm VAS 
questionnaire was only lower in corn bran muffin. These results indicate fiber type is an 
important component in effects of subjective satiety. Subjective satiety is highly variable 
between subjects and increased satiety does not always lead to reduced intake and vice 
versa. Bodinham et al. (2010) showed 80g of RS (60%) split between breakfast and lunch 
meals in 20 young adults lowered energy intake in ad-libitum dinner meal and over the 
entire 24-hour period as measured by diet diaries, but had no effect on subjective appetite 
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ratings. Kendall and others (2010) found opposite results in that subject appetite ratings 
measured by satiety quotient were lower at 15, 30, and 45 minutes  postprandial and found 
a trend for average satiety to be lower during entire 2-hour post-meal time period with a 
25g dose of a RS2 cereal bar compared to control. After 2 hours, subjects were then given 
an ad-libitum test meal consisting of pizza, and there were no difference in food intake with 
treatment. To further complicate findings, Raben and colleagues compared 50g raw potato 
starch (54% RS2) with fully-digestible starch mixed with non-nutritive syrups in 5 male 
participants. They found the fully digestible starch supplementation increased satiation up 
to 6 hours post prandial compared to RS supplementation, but RS treatment lowered 
postprandial glucose and insulin. Differences in satiation of these results may be due to 
differences between physical forms of treatments. The RS treatment was of liquid form and 
control was of gel form and research has shown liquids produce less satiating effects 
postprandial than solid foods (Mourao et al. 2007).   
 
 
Table 4: Effects of resistant starch on satiety responses and food-intake in humans 
Authors Subjects Methodology Test Meal Measurements Results 
Raben et al. 
1994 
n=5 
Age: 20-31 
y.o. 
Sex: M 
 
Healthy 
adults of 
ideal body 
weight 
Cross-over 
design of two 
test meals 
preceded by 3 
day controlled 
diet (60% 
carbohydrate, 
28% fat,  
12%  protein) 
50g RS2 
(54.1%) in 
potato starch  
or 50 g 
pregelatinized 
potato starch 
(100% 
digestible) 
mixed into 500 
mL diluted 
artificially 
sweetened 
fruit syrup 
Satiety every 
30 minutes 
after the meal, 
using 
100-mm VAS 
 
Postprandial 
satiety GIP and 
GLP-1 satiety 
peptides 
Significant ↑ in 
fullness and 
satisfaction 6 
hours after 
consumption in 
starch meal not 
RS 
 
Starch test meal 
had spikes in 
GLP-1 and GIP 
with no change 
from RS meal 
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Table 4. (continued) 
Anderson et 
al. 2010 
n=17 
Age: 20 y.o. 
Sex: M 
 
Healthy 
adults of 
ideal body 
weight 
Cross-over 
design of 5 
soups 
containing 50 
g 
maltodextrin, 
whole-grain, 
high-amylose, 
regular 
cornstarch, or 
no added 
starch at 1-wk 
intervals. 
50g RS2 (dry 
weight) in 
tomato soup 
from whole-
grain (Hi-
maize), high-
amylose (Hi-
maize 260) 
regular 
cornstarch 
(MELOJEL) 
Food intake 
(kcals) from 
post-meal 120 
minutes after 
ingestion of 
test meal 
 
Subjective 
appetite were 
measured at 
140, 155, 170, 
185 and 200 
min after post 
meal 
Post meal intake 
after RS 
treatment was 
decreased (9%-
17%) compared 
to control 
 
Trend for decline 
in average 
appetite under 
the curve  after 
RS treatment 
compared to 
control 
Willis et al. 
2009 
n=20 
Age: 29 y.o. 
Sex: 13 F, 7 
M 
 
Healthy 
adults of 
ideal body 
weight 
Cross-over 
design of 5 
test meals of 
muffins 
containing 
different fiber 
types and 
control 
9g RS2 of β-
glucan, oat, 
corn bran, 
polydextrose  
VAS satiety of 
fullness, 
satisfaction, 
hunger, and 
prospective 
consumption 
Less mean AUC 
for prospective 
consumption in 
RS and corn bran  
 
RS muffin 
increased  
fullness and 
satisfaction 3 
hours 
postprandial 
compared to 
other fibers 
Bodinham et 
al. 2010 
n=20 
Age: 25 y.o. 
Sex: M 
Healthy 
adults of 
ideal body 
weight 
Cross-over 
design of 2 
day test 
breakfast and 
lunch meals  
containing 
mousse of 
high and low 
RS 
80g (60%)  and  
40 % RDS 
(Hi-Maize® 260 
product) 
VAS satiety of 
fullness, 
satisfaction, 
hunger, and 
prospective 
consumption 
 
24-hr diet 
diaries upon 
completion of 
each visit 
 
No difference in 
VAS satiety 
scores between 
treatments 
 
Lower 24hr food 
intake after RS 
supplementation 
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Table 4. (continued) 
Kendall et al. 
2010 
N=22 
Age: 26 y.o. 
Sex: 9 F, 13 
M 
 
Healthy 
adults of 
ideal body 
weight 
 
5 tests meals 
consisting of 
cereal bar and 
beverage of 
varying  levels 
of RS  
 
0g, 5g, 15g, & 
25g RS3 (58%) 
in  in cereal 
bar  
 
(PROMITOR™ 
Tate and Lyle 
Ingredients 
America, 
Decatur, IL) 
Satiety 
quotient using 
VAS 
questionnaire 
 
Food intake 
120 minutes 
after cereal 
bar 
consumption 
Greater satiety 
quotient  in 25g 
RS than all other 
treatments up to 
1 hour 
postprandial 
 
No change in 
meal intake with 
treatment 
RS=resistant starch, VAS= visual analog scale, 
 
To summarize, studies examining resistant starch, satiety, and food intake in humans 
have provided mixed results (Table 4). The level of subjective satiation does not always 
predict food intake, but reduction in food intake is the primary goal of increased satiety to 
improve health. If decreased food intake is the primary goal, regardless of the effects on 
subjective satiety, then resistant starch content needs to be at least 50% of total starch 
ingested in doses of 15 g or more per meal to reduce food intake in subsequent meals and 
24-hour intake. However, further research is needed to substantiate the effects of RS on 
increasing satiety and lowering food intake and to determine specific recommendations for 
RS supplementation to experience these effects. 
 
Resistant Starch and Adverse Effects 
There appears to be minimal adverse effects associated with resistant starch 
consumption. In all aforementioned studies, those noting gastrointestinal discomfort all 
showed minimal effects of RS on negative GI symptoms such as bloating, pain, gas, and 
diarrhea. In a study of 41 healthy young adults, Storey et al. (2007) examined adverse GI 
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symptoms from acute and chronic consumption of varying levels of RS3.  Subjects 
consumed 20, 40, 60, 80, 100 or 120 g (total starch) of RS3 containing starch products (> 
50% RS of total starch) into daily meals on individual test days. Subjects recorded incidence 
and magnitude of GI responses and bowel movements 24 hours following each treatment.  
Results showed no significant differences in the number of subjects experiencing any 
symptom following consumption of 0–60 g RS3 (20-120g servings of total starch) or in 
frequency and consistency of bowel movements in 24 h following consumption. When long-
term consumption was analyzed, subjects consumed RS3 for a period of 3 weeks, with 
increasing doses reaching 10 grams above the level noted to induce gastrointestinal 
symptoms from the short-term study, they found a small yet significant increase in report of 
GI symptoms. Flatulence, bowel frequency, watery feces increased as RS3 dose increased. 
From these results, it can be concluded that RS doses needed to produce significant changes 
in postprandial blood glucose, insulin, and satiety (120g of 50% RS) are not associated with 
any significant discomforting GI symptoms. 
 
Summary of findings 
High glycemic foods appear to be detrimental to health as diets with greatest 
amount of high GI foods are associated with obesity, abdominal obesity, insulin resistance, 
and Type 2 Diabetes. GI of foods have profound effects on postprandial glucose and insulin 
metabolism that can be contributed to the development of chronic disease and reduced 
health. This is why encouragement of low glycemic foods and high fiber intake through 
resistant starch supplementation is suggested to control glucose and insulin levels and 
36 
 
prevent disease progression. Several studies have confirmed this in normal, overweight, 
hyperinsulinemic and Type 2 diabetic adults. To attain significant biological effects, 
approximately 40-60 g doses (total starch dry weight) are needed for reductions in 
postprandial glucose and insulin and 100 g doses are needed to improve insulin sensitivity. 
Moreover, because resistant starch lowers peak blood glucose levels, delays blood glucose 
decline and escapes digestion to be fermented in the large intestine it is thought to 
decrease appetite, control weight, and improve bowel health. The ability for RS to decrease 
appetite, improve satiation, reduce intake, and control weight is less clear and more 
research is need to confirm these benefits. Subjective appetite is very complex and there is 
not conclusive evidence to determine increased satiation with fiber type and dose. 
However, current research suggests 80-100 gram doses over a 24-hour period may be 
needed to reduce food intake (Table 2). Fiber can be associated with uncomfortable 
gastrointestinal side effects such as bloating, diarrhea, gas, and pain. Although, minimal 
gastrointestinal side effects are seen with levels needed to produce biological significant 
effects on postprandial glucose, insulin and satiety. Resistant starch is a relatively new 
discovery, and its use as a tool for control of glucose and insulin metabolism and satiety and 
weight management is promising. Research developing resistant starch products for 
commercial use is an area to consider as this will be able to increase fiber intake on a larger 
scale and help combat the development and globalization of obesity and Type 2 diabetes. 
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CHAPTER III: RESISTANT STARCH CORN PORRIGES LOWERS POSTPRANDIAL BLOOD 
GLUCOSE WITH NO EFFECT ON SUBJECTIVE SATIETY OR 24 HR INTAKE IN NON-
OVERWEIGHT AND OVERWEIGHT ADULTS 
 
Abstract 
Three resistant starch corn porridges made from cornmeal of differing amylose content 
were fed to non-overweight and overweight human subjects. Effects of resistant starch 
level ( 0.8 g, 2.0 g, and 7.5 g RS  or 3%, 8%, and 30% of total starch respectively)  on 
postprandial blood glucose and satiety responses were compared in non-overweight 
 and overweight human subjects. Responses were measured at baseline and 3 hours after 
consumption of each resistant starch test meal. It was hypothesized that overweight 
subjects would have higher blood glucose lower subjective satiety after all treatments. 
Plasma glucose was hypothesized to be lowest and satiety response would be highest in 
highest resistant starch treatment. Moreover, it was hypothesized that increased satiety 
with high resistant starch treatment would result in lower food intake over 24-hour period 
for all subjects. There were no differences between non-overweight and overweight groups 
in any response. Resistant starch supplementation improved peak acute post-prandial 
glucose responses and blood glucose area under the curve with the highest RS dose, but 
had no effect on subject satiety or 24-hr food intake. It may be that doses of RS greater than 
7.5 g per meal or 30% of starch ingested are needed to increase satiety and decrease food-
intake in 24 hour period. 
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Introduction 
High glycemic foods appear to be detrimental to health, as several observational studies 
have shown, diets with the highest glycemic index (GI) foods  are associated with obesity, 
abdominal obesity, insulin resistance, and Type 2 Diabetes (Hu et al. 2011; Halton et al. 
2008; Krishnan et al. 2007; Villegas, 2007).  The GI of foods has profound effects on 
postprandial glucose and insulin metabolism that can be contributed to the development of 
chronic disease and reduced health (Musselman et al. 2011; Pawlak et al. 2004).  Moreover, 
high consumption of rapidly digestible starches cause rapid spikes in blood glucose 
concentration (Ells, 2005) that can lead to hyperinsulinemia and over time may contribute 
to the decline of insulin function resulting in chronic hyperglycemia.  
For example, Ells et al. (2005) compared postprandial blood glucose, insulin and non-
esterifried fatty acids (NEFA) after consumption of a meal containing 75 g rapidly digestible 
starches (RDS) to 75 g slowly digestible starch with 21g of fat in 10 healthy female 
volunteers. They found more rapid and higher peaks of plasma glucose and insulin in the 
first 30-60 minutes after consumption of RDS meal and similar high and rapid peaks in NEFA 
4-6 hours postprandial indicating starch type effects on carbohydrate and fat metabolism. 
In another study, RS produced comparable results in postprandial glucose, insulin, and NEFA 
after a meal tolerance test in 10 healthy subjects following 24 h consumption of 100g RS2 
consisting of 60% RS distributed in 25g doses compared to 40g RDS delivered in 10g dose in 
a diet of 42% carbohydrate (Robertson et al., 2003).  These results show starch type can 
acutely affect insulin and glucose homeostasis and that long-term intake of simple 
carbohydrates may affect carbohydrate and fat metabolism resulting in obesity and DM2. 
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This is futher confirmed in research conducted by Pawlak et al. (2004) examining effects of 
the dietary glycemic index on adiposity, glucose homoeostasis, and plasma lipids in rats fed 
high and low GI diets. Diets were of the same macronutrient content, (69% carbohydrate, 
20% protein, and 11%) but rats fed a high GI diet were fed starch made of 60% amylose and 
rats fed a low GI diet were fed starch made of 100% amylopectin.  Rats fed the high GI food 
had similar body weight compared to low GI but almost twice the amount of body fat and 
less lean body mass. Rats fed high GI diet had greater areas under the curve for blood 
glucose and plasma insulin after a glucose tolerance, lower plasma adiponectin 
concentrations (levels are inversely associated with obesity), higher plasma triglyceride 
concentrations, and severe disruption of pancreatic islet-cell architecture. When Pawak and 
others (2004) conducted a similar experiment with high and low fat diets, they found no 
difference in body fat accumulation between treatments, but less glucose uptake and 
plasma insulin in rats fed the high-fat diet. These findings suggest both excess fat and 
carbohydrates play a role in the development of DM2. Although when wild-type Drosophila 
melanogaster (fruit flies) were fed high-fat, high-sugar, and control diets, larvae fed high-
sugar diets developed hyperglycemia, obesity and insulin resistance, while insulin resistance 
was not seen in the high-fat diet suggesting carbohydrate quality plays a greater role in the 
decline of insulin function (Musselman et al. 2011). 
 As insulin function declines, glucose intolerance ensues causing high blood glucose 
levels that are harmful to the macro and micro vascular functions of the body resulting in 
DM2 diagnosis. Macrovascular complications can lead to heart disease and stroke. 
Microvascular damage can cause nephropathy leading to kidney failure, retinopathy 
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resulting in blindness, and neuropathy eventually leading to amputation (Nelms et al. 2007). 
This is why encouragement of low glycemic foods and high fiber intake through resistant 
starch supplementation is suggested to control glucose and insulin levels and prevent 
disease progression. Resistant starch is any starch that escapes digestion in the small 
intestine to be metabolized in the colon. Several studies have confirmed improved post-
prandial plasma glucose and insulin profiles after RS substitution in normal weight, 
overweight, hyperinsulinemic, and Type 2 diabetic adults (Behall & Scholfield, 2005; Behall 
& Hallfrisch, 2002; Robertson et al. 2003; Mitra et al. 2007). Moreover, because resistant 
starch can lower peak blood glucose levels, delay blood glucose decline and escapes 
digestion to be fermented in the large intestine it is thought to decrease appetite, control 
weight, and improve bowel health. There is much evidence supporting resistant starch 
supplementation and improved bowel health. This is due to increased colonic pH and short-
chain fatty acid production as well as decline in carcinogenic by-products, ammonia and 
phenols, of protein fermentation with consumption of resistant starch (Phillips et al. 1995; 
Noakes et al. 1996; Cummings et al. 1996). However, evidence is less definitive for 
improvement in appetite and reduction of energy intake as a means of controlling weight 
with RS supplementation. There have been a few promising studies showing substitution of 
resistant starch in daily meals can lead to increased feelings of satiety,  reduced intake in 
subsequent meals, and over 24 h periods (Kendall et al. 2010; Bodinham et al. 2010; 
Anderson et al. 2010). Resistant starch is a relatively new finding (Jenkins et al. 1981), and 
more research is needed to make clear recommendations on dosing to provide 
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improvement in both glucose metabolism and satiety measures that will lead to improved 
long-term health by reducing prevalence of obesity and type 2 diabetes development.   
Several diet and lifestyle factors contribute to the development of obesity and DM2. 
In an observational study examining diet and lifestyles factors of  84,941 nurses over a 16-
year period, incidence of DM2, physical inactivity, cigarette smoking, poor quality of fats 
and carbohydrates , and excessive calorie intake were significant risk factors for the 
development of DM2  independent of overweight or obese status (Hu, 2001).   Although 
these lifestyle factors contribute to the development of this negative health condition, 
obesity is the single most important risk factor for DM2, and high abdominal obesity, 
(absolute waist circumference >102 cm (40 in) in men and >88 cm (35 in) in women) 
regardless of weight categorization, is another critical risk factor in DM2 development (Hu, 
2011). There has been little research conducted comparing glucose and satiety metabolism 
between non-overweight individuals and overweight and obese individuals. More research 
examining differences in post-prandial glucose and satiety between these groups may 
provide useful information about obesity and DM2 development and resistant starch 
supplementation. 
Better understanding of the physiological effects of carbohydrates on metabolism 
will help develop recommendations for intake of carbohydrates and resistant starch. These 
will be important for improving health and combating the globalization of obesity and DM2. 
Therefore, the purpose of this study was to examine the effects and compare differences of 
resistant starch corn porridges on post-prandial glucose and satiety response in non-
overweight weight and overweight adults. 
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Materials and Methods 
 
Subjects 
Twenty healthy subjects (10 males and 10 females) mean age 25 ± 4 years were recruited 
for the study. Subjects were classified according to body mass index (<24.9 and >25.0 
kg/m2) with a mean BMI of 20.9 ± 1.4 and 28.8 ± 4.7 kg/m2 respectively. There were five 
males and five females in each BMI group. Subjects were healthy, limited alcohol drinkers  
consuming  < 1 alcoholic serving per day and not taking any medications in the past 6 
months. 
 
Protocol 
Subjects were recruited from the Nutrition and Wellness research center at Iowa State 
University and visited the center 3 times, separated at least 2 days apart. On test days, 
subjects arrived in the morning after a 12 hour overnight fast. Upon arrival, baseline blood 
glucose was measured with a glucometer (ReliOn® Confirm, ARKAY USA, Minneapolis, MN), 
and a Visual Analog Scale (Greenway et al. 2007) was administered to determine, hunger, 
satisfaction, fullness, and desire. Blood glucose was measured at base 15, 30, 60, 120 
minutes after the test meal and the VAS was administered 30, 60, 120, 180 minutes after 
consumption of test meal. Subjects were given a food log and gastrointestinal symptoms 
questionnaire upon completion of each visit and asked to record all food and beverage 
consumption and gastrointestinal symptoms over the following 24 hours. 
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Resistant starch 
 Corn samples used were grown at the ISU agronomy farms in 2009. Three different corn 
lines were planted: a high amylose, low amylose control, and a hybrid of the two. The 
inbred high amylose corn line: GUAT209:S13//Oh43ae/H99ae-1-2-1)-B-B-02was planted in 
200 rows. The control inbred corn line:AR011050:S01:1082]-09-02 was planted in 200 rows. 
The hybrid corn line: GUAT209:S13// Oh43ae/H99ae-1-2-1)-B/3/AR011050:S01:1082)-03)-
02-10 was planted in 267 rows. The plants were self-pollinated and hand harvested, dried in 
a forced-air dryer at room temperature, mechanically shelled, and the seed was bulked. 
Samples were analyzed for mycotoxins at the Veterinary Diagnostic laboratory at North 
Dakota State University prior to study. 
 
Test Meals 
The three corn lines were consumed by subjects as a corn porridge breakfast. Test meals 
were consumed by participants in a cross-over randomized block design.  Each test meal 
was taken with 200 ml of water and consumed within 15 minutes. 
 
Porridge formulation and Resistant Starch Analysis 
The porridge recipe consisted of 3 ingredients: cornmeal, water, and sucralose. Cornmeal 
was made from the aforementioned 2009 corn lines. The three varieties were ground in the 
pilot plant at Iowa State University’s Center for Crops Utilization Research. Samples were 
ground twice using a Fitz Mill, Comminuting Mill Model #DA606 (The Fitzpatrick Company, 
Elmhurst, IL).  A 3.18 mm (screen #1531-0125) sieve was used for the first grind at 3,003 
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RPMs. And a 1.02 mm sieve (screen #1532-0040) was used for the second grind at 7,000 
RPMs. Samples were stored at 4°C. Cornmeal weight per serving was calculated using 25 g 
dry weight of total starch because 50 g was too large a portion for a single meal, given the 
volume to be consumed. Total cornmeal needed for single serving of porridge equated to 
approximately 29 g. Porridges consisted of 9 times their weight in water as this was the 
least amount of water needed to have acceptable consistency for the assay and similarities 
of treatments. A small amount (0.025 g) of sucralose was added for sweetness 
Resistant starch content of the 
three corn varieties were analyzed 
using Megazyme AOAC Method 
2002.02. Because analysis was on a 
wet basis pancreatic amylase was added according to solid content of porridge. Total starch 
was analyzed separately with Megazyme AOAC Method 996.11. Digestible starch was 
calculated by subtracting resistant starch from total starch. Starch content of the three corn 
varieties used in test meal is shown in Table 1. Based on starch content analysis, GUAT, 
AR/GUAT, and AR contained approximately 18 g of total starch and 5.2 g, 1.5 g, and 0.5 g of 
resistant starch.   This equates to approximately 30%, 8%, and 3% resistant starch doses for 
each treatment respectively. Levels of RS used in study were based on amount in each corn 
line variation and appropriate meal size for consumption by subjects. 
 
 
 
Table 1. Resistant Starch (RS), digestible starch (DS),  
and total starch (TS) contents of porridge (dry basis)a 
Sample RS (%) DS (%) TS (%) 
GUAT 2009 18.0 + 0.10 44.2 + 0.3 62.2 + 0.4 
AR/GUAT 2009 5.3 + 0.0 57.8 + 0.8 63.1 + 0.8 
AR 2009 2.0 + 0.1 61.6+ 0.3 63.7 + 0.3 
aThe solid content of the porridge was 9.8% 
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Blood analysis 
Blood glucose was measured through finger prick analysis using a glucometer (ReliOn® 
Confirm, ARKAY USA, Minneapolis, MN). ReliOn® glucometer coefficient of variation 
averages 2.9% between consecutive glucose readings and has a correlation coefficient of 
0.98. 
 
Appetite Analysis 
 Satiety was measured using a 100 mm line Visual Analog Scale (Greenway et al. 2007). 
Subjects were asked to indicate level of hunger, fullness, satisfaction and desire to eat by 
marking a position along a continuous line between 0 and 100mm (Appendix A). 
 
Food intake 
Subjects were instructed to keep a 24-hour food diary recording amounts of all food eaten 
after completion of each visit. They were provided with a form to record intake and diets 
were checked and clarified for portion sizes upon return of the forms. Energy intake was 
measured using Nutritionist Pro™ Dietary Analysis software (AXXYA SYSTEMS LLC, Stanford, 
TX). 
 
Gastrointestinal Symptoms  
Subjects recorded gastrointestinal symptoms with questionnaire of overall symptoms, and 
time and onset of specific GI symptoms 24-hours after each treatment. Symptoms were 
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rated on a scale from 0 to 10 with 0 indicating no discomfort and 10 indicating extreme 
discomfort (Appendix A). 
 
Statistical Analysis 
Data was fit to a linear model (PROC GLM, v.9.2, SAS Institute, Cary, NC) where subjects 
were treated as random block effects to create correlations between subjects and 
treatments. Mean values and AUC were analyzed for plasma-glucose and satiety.  Area 
under the curve was measured using trapezoidal method. Two-way interactions were 
evaluated between time with treatment, gender and weight classification. Main effects 
analyzed for blood glucose, satiety, and food intake. The significance level was set at P < 
0.05. 
 
 
Results 
 
Mycotoxin analyses of corn meals 
Corn meals from each of the corn lines showed no detectable contamination for any 
mycotoxin tested at the Veterinary Diagnostic laboratory at North Dakota State University. 
 
Glucose Responses 
There were no differences in post-prandial glucose responses when treatments were 
categorized by gender or weight group (Figures 2,4).   The post-prandial blood glucose 
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response of high RS GUAT porridge at 30 minutes was significantly lower compared to 
GUAT/AR (p=0.0208) and AR porridge (p=0.0003) responses (Figure 3). Baseline-adjusted 
blood glucose area under the curve was reduced by 10% (p=0.0185) and respectively 
compared to AR porridge (Figure 1). There were no differences in post-prandial glucose 
responses between GUAT/AR and AR porridges.  
 
Figure 1.Baseline adjusted post-prandial blood glucose responses measured as area under the curve 120 min after 
consumption of AR (3% RS), GUAT/AR (8% RS), GUAT (30% RS) corn porridges. Data represented as mean ± SE, n=20. 
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Figure 2. Comparison of non-overweight (BMI < 24.9) and overweight (BMI >25) baseline adjusted post-prandial blood 
glucose responses measured as area under the curve 120 min after consumption of AR (3% RS), GUAT/AR (8% RS), GUAT 
(30% RS) corn porridges. Data represented as mean ± SE, n=10.  
 
Figure 3. Post-prandial blood glucose responses 120 minutes after consumption of AR (3% RS), GUAT/AR (8% RS), GUAT 
(30% RS) corn porridges. Data represented as mean ± SE, n=20. Significance level p<0.05* 
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Figure 4. Comparison of non-weight (BMI <24.9) and overweight (BMI >25) post-prandial blood glucose responses 120 
min after consumption of AR (3% RS), GUAT/AR (8% RS), GUAT (30% RS) corn porridges. Data represented change in 
mean blood glucose after baseline, n=5 . Standard Error was omitted for clarity. Results were not significantly different. 
 
Subjective Satiety responses and food intake 
Baseline-adjusted satiety responses (hunger, satisfaction, fullness, and desire) were not 
different between RS porridges (Figure 5 ). There were also no trends or differences 
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between ideal weight and overweight subjects (Appendix B). 
 
Figure 5. Baseline adjusted area under curve of satiety responses after subjects consumed 3 corn porridges with 
increasing level of resistant starch. Data represented as means ± SE, n=20. 
 
 
Food Intake 
There was a slight tendency for 24 h food intake to decline with increasing RS dosage. 
Calorie intake was 1907 ±800, 1831± 543, and 1787± 758 kcals during 24 hours after 
consuming AR, GUAT/AR, and GUAT porridges respectively, but this was not significant.  
 
Gastrointestinal Symptoms 
Very few subjects reported adverse gastrointestinal symptoms in the 24 hours following 
porridge consumption. In the lowest RS dosage (AR), 3 people reported mild gas, bloating or 
diarrhea and five people reported similar results after GUAT/AR porridge ingestion. The 
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
A
U
C
 (
m
m
*m
in
) 
Satiety Measure 
AR (3% RS)
AR/GUAT (8% RS)
GUAT (30% RS)
59 
 
highest RS dosage (GUAT) had one participant report severe pain of short duration but 
rated overall discomfort in 24 h period as minimal. 
 
Discussion 
 
Glucose Responses 
We hypothesized that mean post-postprandial glucose response would decline as RS dose 
was increased in the porridge test meal. This was confirmed with our results as peak 
glucose responses and blood-glucose AUC were reduced in the 30% RS GUAT corn porridge 
compared to 8% RS GUAT/AR and 3% RS AR corn porridges (Figures 1, 3). The glucose 
response tended to decrease with increasing RS dose; however, this was not significant. 
These results suggest doses between 30% RS of total starch or approximately 5g doses are 
needed to produce significant biological changes in post-prandial glycemia. Previous 
findings of resistant starch dose and postprandial glycemia show effects begin to occur 
around 15% RS of total starch or approximately 5 g dosages (Behall & Howe, 1995; Behall et 
al. 1989; Behall et al. 2002).  For example, a two-day controlled diet, followed by a 
tolerance test of either glucose solution or breads containing 2%, 8%, 12% and 15% of  RS2 
(American Maize-Products Company, Hammond, IN) confirms this effect (Behall et al. 2002).
 Moreover, Li et al. (2010) found similar declines in both postprandial glucose and 
insulin responses after subjects consumed rice providing 20% RS, equal to 8 g of RS in 40 g 
carbohydrate load. In our study, the resistant starch load was approximately 30% RS, equal 
to 5 g of RS in a 25 g (dry-weight) carbohydrate load.  However, Jenkins et al. (1998) and 
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Kendall et al. (2010) observed no change in acute postprandial blood glucose and insulin 
responses after consumption of approximately 30 g and 25 g RS doses respectively. This 
may be due to flaws in design rather than the effect of high resistant starch doses. Jenkin’s 
test meals provided equal amounts of available carbohydrate and Kendall did not specify 
total or available carbohydrate loads in test meals. Equal amounts of carbohydrate loads 
should produce similar effects regardless the amount of RS because there is an equal 
amount of starch contributing to the rise is plasma glucose. Moreover, the main mechanism 
for using resistant starch as a tool for controlling postprandial glycemia is that a percentage 
of the total starch in a carbohydrate load is resisting digestion; therefore, less available 
starch is contributing to the rise in plasma-glucose compared to an equal starch load of fully 
digestible starch. Perhaps standardization of RS dosage in treatments is needed to help 
make better sense of results and develop concise recommendations for RS 
supplementation. Based on previous literature and our current findings, 5 g doses of RS or 
15% RS of total starch in a standard 25-50 g carbohydrate load is needed to improve 
postprandial blood glucose 
 
Satiety Responses 
Our study did not show any differences in satiety measures between RS treatments (Figure 
5, Appendix B). Previous research examining the satiety effects of RS have provided mixed 
results (Raben et al. 1994; Anderson et al. 2010; Bodinham et al. 2010; Kendall et al 2010). 
We hypothesized that the 30% RS GUAT porridge would be the most satiating by reducing 
hunger and desire to eat and increasing satisfaction and fullness compared to the 8% and 
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3% treatments. Satiety and appetite regulation are very complex and are influenced by 
several factors such as environmental cues, psychological perceptions of hunger, and 
individual metabolism and physiology that produce neuronal cues leading to ingestion of 
food (Bornet et al. 2007). Resistant starch has been proposed to influence satiety and 
control weight through several different mechanisms. One mechanism, and the basis for 
our hypothesis, is the steady release of postprandial blood glucose from consumption of 
resistant starch due to delay of gastric emptying into the small intestine. This delay causes a 
decline in blood glucose to pre-meal leaves that would signal hunger and increase appetite. 
This relates to Jean Mayer’s glucostatic theory (1953) elucidating the effect of glucose levels 
on appetite as he found low glucose levels are associated with hunger in both normal and 
insulin resistant individuals. A second mechanism of increased satiety through resistant 
starch supplementation is the interaction between SCFAs in the colon and satiety 
hormones. Short-chain fatty acids in the large intestine are proposed to increase satiety by 
their release form the hepatic, portal, and venous blood that reduce production of fatty-
acids from visceral adipose tissue providing an energy source in post-absorptive state 
(Cummings et al. 1987). Consequently, this affects physiology of metabolism and neuronal 
pathways of food intake. A few studies have shown interaction between fermentation of RS, 
increase SCFAs, and changes in satiety hormones GLP-1 and PPY, associated with increased 
satiety and reduced food intake, in both rats and humans. In a series of experiments by 
Zhou and others (2008), Sprague-Dawley rats fed resistant starch showed increased GLP-1 
and PYY expression and secretion compared to control. Furthermore, when seven 
overweight and obese human subjects consumed 4 g of RS3 (barley and oat mixture) per 
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day for 14 weeks, fasting GLP-1 and PYY were increased, and subjective satiety was 
increased 1 hour after a standard meal (Greenway et al. 2007). The decrease in subjective 
satiety through the effects of increased SCFA post-prandially on satiety hormones has 
shown a few positive results, but more research is needed to substantiate these claims and 
identify mechanisms. We also hypothesized that this increase in subjective satiety would 
lead to a reduction in total energy intake over 24 hour period following consumption of RS.  
Controlling body weight by RS consumption is achieved through two basic mechanisms: 1) 
increased satiation reduces subsequent food intake 2) less available energy in resistant 
starch compared to digestible starch of same load give less energy intake and less energy 
intake leads to weight loss or weight control.  As with previous literature looking at 
subjective satiety and resistant starch substitution, evidence for increased satiation and 
reduced food intake has shown mixed results. Anderson et al. (2010) examined second meal 
intake of 17 healthy males 2 hours after consumption of a 3 tomato soups containing 50 g 
of RS. The amount of RS in soup treatment was correlated with reduced food intake at 120 
min. The whole-grain soup (27g RS2), high-amylose soup (23g RS2) and regular cornstarch 
soup (19g RS2) had a 17%, 10%, and 10% decline in food intake respectively. Additionally, 
whole-grain soup was the only treatment that resulted in lower cumulative energy intake 
and there was a trend for decline in average appetite area under the curve after RS 
treatments compared to control. The decline in food intake was thought to be caused by 
the release of SDS that occurs up to 120 minutes post-prandial, which delays decline in 
blood glucose levels to baseline that would initiate feelings of hunger. Additionally, the 
types of fiber sources (i.e. soluble vs. insoluble) may play a role in differences between 
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results. In a study where postprandial satiety was compared in 5 muffins of different fiber 
content (9g of RS2, β-glucan, oat, corn bran, polydextrose)  in 20 subjects, Willis and others 
(2009) found RS muffins were the most satiating in satisfaction and fullness up to 3 hours 
postprandial, and corn bran muffins had similar results for fullness only. Prospective 
consumption measured on 100mm VAS questionnaire was only lower in corn bran muffin. 
These results indicate fiber type is an important component in effects of subjective satiety. 
Subjective satiety is highly variable between subjects and increased satiety does not always 
lead to reduced intake and vice versa. Bodinham et al. (2010) showed 80 g of RS (60%) split 
between breakfast and lunch meals in 20 young adults lowered energy intake in ad-libitum 
dinner meal and over the entire 24-hour period as measured by diet diaries, but had no 
effect on subjective appetite ratings. Kendall and others (2010) found opposite results in 
that subject appetite ratings measured by satiety quotient were lower at 15, 30, and 45 
minutes  postprandial and found a trend for average satiety to be lower during entire 2-
hour post-meal time period with a 25g dose of a RS2 cereal bar compared to control. The 
level of subjective satiation does not always predict food intake, but a reduction in food 
intake is the primary goal of increased satiety to improve health. If decreased food intake is 
the primary goal, regardless of the effects on subjective satiety, then resistant starch 
content needs to be at least 50% of total starch ingested in doses of 15 g or more per meal 
to reduce food intake in subsequent meals and 24-hour intake. However, further research is 
needed to substantiate the effects of RS on increasing satiety and lowering food intake and 
to determine specific recommendations for RS supplementation to experience these effects 
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Differences between weight groups 
Our study did not show differences in blood glucose (Figure 2) or satiety between 
weight groups (Appendix B). This may be due to the fact that the majority of the overweight 
group had a body mass index between 25.0 – 29.9 kg/m2. Two subjects in the overweight 
group were considered obese by BMI (30.3 and 41.2 kg/m2). The 2 obese subjects had an 
approximate 20% higher baseline-adjusted glucose AUC compared to normal and 
overweight subjects (according to BMI). The 2 obese subjects also had an approximate 50% 
higher glucose at 60 min compared to normal and overweight subjects (data not shown). 
 
Limitations 
Some of the limitations to our study included frequency of blood glucose 
measurements and small sample size. In a review of GI methodology by Brouns and others 
(2005), it is suggested to measure blood glucose every 15 min for the first 60 min, than 
every half hour for at least 3 hours. Sampling less than recommended frequency leads to 
increase variation between means. A sample size of 10 subjects appears to be adequate for 
measuring differences in glycemic response, but 20 to 40 subjects are recommended for 
greater power and precision in detecting differences. We had 10 subjects in each weight 
group and 20 for each treatment although baseline characteristics (i.e. body mass index) 
were not the same for the 20 participants which could have influenced results. Moreover, 
satiety measurement and 24 h food dairies could have been more precise. For example, a 
secondary meal intake 2-3 h after test meal could have been given to measure satiety 
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through reduction in food intake, and a scale could have been given to subjects to weigh 
food intake over the 24-h period following each visit to insure portion size.  
 
 General Conclusions 
Our results indicate that a 7.5 g dose of resistant starch or 30% RS in total starch can 
reduce postprandial blood glucose. However, this dose was insufficient to increase 
subjective satiety 3 h postprandial and/or reduce energy intake 24 h following 
consumption.  Literature suggests 5 g doses or 15% RS in total starch is needed to improve 
postprandial blood glucose, and 15 g doses or 50% RS in total starch is needed to reduce 
energy intake in subsequent meals and daily intake. 
 
Future research 
This study provides evidence for use of RS as a tool for lowering postprandial 
glycemia in normal weight and overweight adults; however, more research needs to be 
conducted in obese and DM2 individuals as they may benefit most from resistant starch 
effects. Moreover, long-term studies on satiation and food intake from RS substitution are 
needed to make better recommendations on supplementation. Finally, developing products 
with high doses of resistant starch for large scale production and commercial use such as 
breads, cakes, muffins, and rice are needed to help combat globalization of obesity and  
DM2. 
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APPENDIX A: INFORMED CONSENT DOCUMENT AND DATA COLLECTION FORMS 
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Subject ID:_______________    Date________________ 
Blood Glucose Recording Sheet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time point Blood Glucose (mg/dL) 
  
Baseline  
  
15  
 
30  
 
60  
 
120  
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Visual Analog Scale 
 
Time Point_______________ Subject ID_______________ Date_________________ 
 
Make a mark crossing the scale (line) beneath each question to indicate how you feel (the extremes 
are described at either end of each line). 
 
 
 
 
 
 
How hungry do you feel? 
 
I am not 
hungry at 
all                                                                                                                                                                                                                 
 I have 
never been 
more 
hungry 
 
 
 
 
How satisfied do you feel? 
 
I am 
completely 
empty 
 I cannot eat 
another 
bite 
 
 
 
 
 
How full do you feel? 
 
Not at all 
full 
 Totally full 
 
 
 
 
 
 
How much do you think you can eat? 
 
Nothing at 
all 
 A lot 
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Figure 6. Comparison of normal weight (BMI < 24.9) and overweight (BMI > 25) post-prandial fullness measured as area 
under the curve after subjects marked satiety rating on 100mm line visual analog scale. Data are represented as means 
± SD, n=10. 
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Figure 7. Comparison of normal weight (BMI < 24.9) and overweight (BMI > 25) post-prandial satisfaction measured as 
area under the curve after subjects marked satiety rating on 100mm line visual analog scale. Data are represented as 
means ± SD, n=10. 
 
Figure 8. Comparison of normal weight (BMI < 24.9) and overweight (BMI > 25) post-prandial desire measured as area 
under the curve after subjects marked satiety rating on 100mm line visual analog. Data are represented as means ± SD, 
n=10. 
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Figure 9. Comparison of normal weight (BMI < 24.9) and overweight (BMI > 25) post-prandial hunger measured as area 
under the curve after subjects marked satiety rating on 100mm line visual analog scale. Data are represented as means  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
200
400
600
800
1000
1200
1400
1600
1800
AR AR/GUAT GUAT
A
U
C
 (
m
m
) 
Treatment 
Hunger  
BMI ≤ 24.9 
BMI ≥ 25.0 
77 
 
± SD, n=10. 
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